Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Similar documents
RECTAL CARCINOMA: A DISTANCE APPROACH. Stephanie Nougaret

IMAGING GUIDELINES - COLORECTAL CANCER

COLORECTAL CANCER STAGING in 2010

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

L impatto dell imaging sulla definizione della strategia terapeutica

Role of MRI for Staging Rectal Cancer

Rectal cancer management: a team sport The role of radiology and the multidisciplinary conference

Staging Colorectal Cancer

Imaging in gastric cancer

Advances in Imaging Technology In The Management of Colorectal Cancer

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD

Staging of rectal cancer on MRI: What the surgeons want to know.

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

MRI Rectal Staging Template Revision Summary

MRI in staging of rectal carcinoma

Local staging of colon cancer: the current role of CT

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

Oncology Review article High-Resolution MRI in Rectal Cancer

COLORECTAL CARCINOMA

Cervical Cancer: 2018 FIGO Staging

RECTAL CANCER CLINICAL CASE PRESENTATION

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp

Rectal Cancer: Classic Hits

TME and autonomic nerve preservation techniques: based on Video and Cadaveric anatomy

11/21/13 CEA: 1.7 WNL

Imaging in rectal cancer with emphasis on local staging with MRI

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

Rectal Cancer Update 2008 The Last 5 cm. Consensus Building

CT PET SCANNING for GIT Malignancies A clinician s perspective

Handling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Carcinoma del retto: Highlights

Pancreatic Adenocarcinoma: Everything You Need to Know From Cross-Sectional Imaging to Treatment

Rectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux

Colorectal Cancer and FDG PET/CT

COLON AND RECTAL CANCER

Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management

JMSCR Vol 05 Issue 06 Page June 2017

Local Excision of Rectal Cancer Techniques and Outcomes

PET in Rectal Carcinoma

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Dr. Anat Ravid Surgical Oncology Lead Erie St. Clair Regional Cancer Program May 1, 2014

PET CT for Staging Lung Cancer

New Visions in PET: Surgical Decision Making and PET/CT

COLON AND RECTAL CANCER

Application of Magnetic Resonance Images in Gastrointestinal Malignancies

Adjuvant Chemotherapy for Rectal Cancer: Are we making progress?

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

Accuracy of transvaginal ultrasound and magnetic resonance imaging in diagnosis and extension of pelvic endometriosis

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Index. Note: Page numbers of article titles are in boldface type.

Esophageal Cancer. What is the value of performing PET scan routinely for staging of esophageal cancers

THE ROLE OF HIGH RESOLUTION MAGNETIC RESONANCE IMAGING (MRI) IN DETECTING CIRCUMFERENTIAL RESECTION MARGIN (CRM) FOR THE PROGNOSIS OF RECTAL CANCER

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

Imaging: When to get MRI, CT or PET-CT?

Surgical Therapy of GEP-NET: An Overview

Endobronchial Ultrasound in the Diagnosis & Staging of Lung Cancer

Mini J.Elnaggar M.D. Radiation Oncology Ochsner Medical Center 9/23/2016. Background

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Can MRI Improve Triage of Bladder Cancer Patients. John Chang, M.D., Ph.D. Banner MD Anderson Cancer Center

Local Excision for early rectal cancer

FEMALE PELVIS Normal Tissue RTOG Consensus Contouring Guidelines

Esophageal Cancer: A Multimodality Approach to Detection and Staging

UCL. Rectum Adenocarcinoma. Quality of conformal radiotherapy Impact for the surgeon P. Scalliet & K. Haustermans

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Laparoscopic Resection Of Colon & Rectal Cancers. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

CHAPTER 7 Concluding remarks and implications for further research

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

A916: rectum: adenocarcinoma

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

Pathohistological Assessment of the Circular Margin of Resection During Total Mesorectal Excision, Conducted on The Malignant Formations of the Rectum

Radiology Pathology Conference

Mediastinal Staging. Samer Kanaan, M.D.

MRI of Rectal Cancer

A schematic of the rectal probe in contact with the prostate is show in this diagram.

Staging and Treatment Update for Gynecologic Malignancies

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Restaging Locally Advanced

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

State-of-the-art of surgery for resectable primary tumors

Rectal Cancer. Madhulika G. Varma MD Associate Professor and Chief Section of Colorectal Surgery University of California, San Francisco

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Imaging techniques in the diagnosis, staging and follow up of GI cancers. Moderators: Banke Agarwal, MD and Paul Schultz, MD

Cover Page. The handle holds various files of this Leiden University dissertation.

Preoperative diagnosis and staging of rectal cancer using diffusion weighted and water imaging combined with dynamic contrast enhanced scanning

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER


Pelvic Angiogram - Male

is time consuming and expensive. An intra-operative assessment is not going to be helpful if there is no more tissue that can be taken to improve the

S1.04 PRINCIPAL CLINICIAN G1.01 COMMENTS S2.01 SPECIMEN LABELLED AS G2.01 *SPECIMEN DIMENSIONS (PROSTATE) S2.03 *SEMINAL VESICLES

Disorders of Cell Growth & Neoplasia. Histopathology Lab

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Restaging after neoadjuvant chemoradiation in rectal cancers: is histology the key in patient selection?

بسم هللا الرحمن الرحيم. Prof soha Talaat

Transcription:

What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Zhen Jane Wang, MD Assistant Professor in Residence UC SF Department of Radiology Disclosure None Acknowledgement Hueylan Chern, MD, Department of Surgery, UCSF Rectal cancer imaging Message: Select patients for sphincter preserving surgery and for neoadjuvant therapy Endorectal US and MRI for local staging CT +/- PET for metastases EUS MRI PET 1

EUS Advantages Office Procedure Inexpensive Minimal preparation Mural depth of invasion Limitations Operator dependent Limited field of view EUS: Normal rectal wall Interface balloon & Mucosa Mucosa & Muscularis Mucosa Submucosa Muscularis Propria EUS staging T1: confined to submucosa EUS staging T1: confined to submucosa T2: invades muscularis propria Muscularis Propria 2

EUS staging EUS staging T1: confined to submucosa T2: invades muscularis propria T3: invades perirectal fat T1: confined to submucosa T2: invades muscularis propria T3: invades perirectal fat EUS staging Seminal vesicle T1: confined to submucosa T2: invades muscularis propria T3: invades perirectal fat T4: invades adjacent organ EUS staging T1: confined to submucosa T2: invades muscularis propria T3: invades perirectal fat T4: invades adjacent organ N1 : + node 3

EUS staging Rectal MRI T staging accuracy: 80-95% Superior in T1 vs. T2 staging Permits FNA of nodes Disadvantages: Limited field of view for lymph nodes and mesorectal fascia visualization Puli et al Ann Surg Oncol 2009;16(2):254 Advantages Improved visualization of anatomy, can see high nodal disease and past stenoses MERCURY trial: high res MRI predicts curative resection vs potential failure Limitation Expensive Limited T1 vs T2 staging Sagittal T2 weighted MRI Rectal MRI Technique Rectal MRI Technique Use a surface coil Endorectal coil not needed IV contrast not necessary Bowel preparation Rectal gel controversial No gel for low rectal cancer Include: Pelvic sidewalls Upper mesorectum Sagittal T2 weighted MRI High resolution (small field of view) T2 weighted images ~3mm slice thickness 0.6-0.8mm in plane resolution Axial /coronal planes orthogonal to the rectal wall To improve T2 vs T3 staging 4

Distance from anal verge T2 w sequence Mucosa/Submucos a Hyperintense Muscularis propria Iso to hypointense MRI T staging T1 from T2 difficult Goal is for T2 and above staging T2: tumor invades muscularis propria T3: tumor invades mesorectum T2 w sequence T2 w sequence 5

Advanced T3 disease (> 5mm invasion) Early T3 disease (< 5mm invasion) Advanced T3 disease (> 5mm invasion) MERCURY trial MR excellent for predicting depth of invasion into the mesorectum and CRM involvement by tumor or nodes Within 0.5mm between MR and histopathology MERCURY Study group, Radiology 2007, BMJ 2006 CRM within 1mm of mesorectal fascia MERCURY trial MR excellent for predicting depth of invasion into the mesorectum and CRM involvement by tumor or nodes Within 0.5mm between MR and histopathology MERCURY Study group, Radiology 2007, BMJ 2006 Coronal T2 image Assess relationship to the sphincter complex to determine feasibility Levator ani of sphincter preserving surgery IS puborectalis ES 6

Assess relationship to the sphincter complex to determine feasibility of sphincter preserving surgery Delineating relationship between anterior peritoneal reflection and tumor Invasion through the peritoneal reflection is T4 Coronal T2 image Sagittal T2 image : nodes T4: tumor invades bladder Axial T2 image Sagittal T2 image Coronal T2 image Size 5mm 68% sensitivity 78% specificity Morphology Spiculated margin Heterogenous signal intensity 85% sensitivity, 97% specificity 7

: nodes -Post CRT Size 5mm 68% sensitivity 78% specificity Morphology Spiculated margin Heterogenous signal intensity 85% sensitivity, 97% specificity MR 66% accurate in the prediction of CRM involvement post CRT Fibrosis difficult to differentiate from tumor infiltration 38% tumor over-staged MR findings of persistent potential CRM involvement associated with higher recurrence Chen et al. Dis Colon Rectum 2005;48:722-728 Sagittal T2 image Diffusion MRI Quantifies water molecule movement Many tumors with restricted diffusion (bright on DWI) Not for depth of extramural spread nor to differentiate between benign and malignant nodes Helpful for node localization and treatment response Rectal MRI Standardized Report 8

PET-CT No role in pre-operative primary tumor staging Helpful in M staging Detection of post-surgical recurrence Intravenous contrast for CT PET-CT: initial staging Brush et al. Health Technol Assess. 2011 PET-CT: initial staging PET-CT: Post-treatment T2 weighted MRI PET 9

PET-CT: Post-treatment RF ablation site RF ablation site PET-CT: Post-treatment PET Patient with colon CA CT peri-rectal lymph node recurrence hepatic metastasis in dome (not seen on CT) Patient underwent radiation Post treatment CT PET-CT: Post-treatment No PET activity at site of recurrence c/w treated tumor new disease or treated disease? PET Fused PET-CT 10

PET false positive Inflammatory uptake of FDG mimicking tumor wait 4 weeks after surgery, 3 weeks after radiotherapy Physiologic uptake of FDG muscle, uterus, corpus luteum cyst correlative CT PET false positive Pre-operative MRI Tumor recurrence? PET false positive PET false positive Tumor recurrence? Seminal vesicle PET scan 11

PET false negative Diabetic patients High circulating glucose compete with FDG Small lesions Resolution limit 5-10mm Mucinous carcinoma Take home messages Ultrasound: T staging MR: T staging Depth of extramural spread, mesorectal involvement, predict CRM involvement Visualizing pelvic side wall / high nodes PET/CT Metastatic disease Recurrence Mucinous adenocarcinoma Thank you! Jane.Wang@ucsf.edu 12